DOLPHIN MEDICAL SERVICES LTD.

Rarever Financial Advisors Pvt Ltd, acting as Manager to the Offer, has submitted a Post-Offer advertisement for Dolphin Medical Services Limited. The open offer, initiated by Acquirers Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar, aimed to acquire 39,25,988 equity shares (26% of paid-up capital) at ₹4.80 per share. The offer opened on July 31, 2026, and closed on August 13, 2026. However, the actual number of shares tendered and accepted was significantly lower than anticipated, with only 18,000 shares acquired, representing 0.12% of the equity share capital. The total value of the accepted shares was ₹86,400, a stark contrast to the proposed offer size of ₹1,88,44,743.

Dolphin Medical Services Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026. The company's Board of Directors approved and took on record these results at a meeting held on August 14, 2026. The financial statements were prepared in compliance with Indian Accounting Standards (Ind AS). The results were reviewed by the Audit Committee prior to board approval. The meeting commenced at 6:30 PM and concluded at 8:45 PM.

Dolphin Medical Services Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The board of directors approved and took on record the financial results after review by the Audit Committee. The meeting commenced at 6:30 PM and concluded at 8:45 PM on August 14, 2026. The company prepared its results in compliance with Indian Accounting Standards (Ind AS).

Dolphin Medical Services Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item is to consider and approve the Unaudited Standalone Financial Results for the first quarter ended June 30, 2026. In line with SEBI regulations, the trading window for designated persons has been closed since July 1, 2026, and will reopen 48 hours after the financial results are published.

Rarever Financial Advisors Pvt Ltd, acting as Manager to the Offer, has submitted a Pre-Offer advertisement cum corrigendum to BSE for an open offer by acquirers Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar. The offer aims to acquire 39,25,988 equity shares, representing 26.00% of Dolphin Medical Services Limited's paid-up capital, at a price of ₹4.80 per share. The offer price has not been revised. The Committee of Independent Directors has deemed the offer price fair and reasonable. The Letter of Offer was dispatched to shareholders, and details are available on various websites, including SEBI and BSE.

Rarever Financial Advisors Pvt Ltd, acting as the Manager to the Offer, has submitted a copy of the Recommendations of the Committee of Independent Directors (IDC) of Dolphin Medical Services Ltd to the BSE. This filing pertains to a specific offer or transaction, and the IDC's recommendations are a crucial step in the process, providing an independent assessment for stakeholders. Further details regarding the nature of the offer and the specific recommendations are expected to be disclosed following this submission.

Rarever Financial Advisors Pvt Ltd, acting as Manager to the Offer, has submitted a Letter of Offer (LOF) to the public shareholders of Dolphin Medical Services Ltd. The offer is made by Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar to acquire up to 39,25,988 equity shares, representing 26.00% of the voting capital. The offer price is ₹4.80 per equity share, payable in cash. This open offer is being made pursuant to SEBI (SAST) Regulations, 2011. The offer is not conditional and has no minimum acceptance level. There are no competing offers, and no statutory approvals are currently required for the transaction. The offer price or size may be revised upwards under specific conditions.

Dolphin Medical Services Ltd announced that Ms. Vaishnavi Sharma has resigned from her positions as Company Secretary cum Compliance Officer and Chief Financial Officer. The resignation was accepted by the Board of Directors at a meeting held on July 25, 2026. The company expressed appreciation for her services. The effective date of resignation is the close of business hours on July 24, 2026. This change is disclosed as per SEBI Listing Regulations.

Rarever Financial Advisors Pvt Ltd, acting as the Manager to the Offer, has informed BSE that the identified date for determining shareholders eligible to receive the Letter of Offer for an open offer has been fixed as July 17, 2026. This date is crucial for identifying shareholders as per SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, who will receive the detailed offer documents. The open offer follows a Public Announcement on May 15, 2026, a Detailed Public Statement on May 22, 2026, and a Draft Letter of Offer on June 01, 2026.

Rarever Financial Advisors, acting as the Manager to the Offer, announced a Detailed Public Statement on behalf of Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar (the Acquirers) for an open offer to acquire up to 39,25,988 equity shares of Dolphin Medical Services Limited, constituting 26% of the total paid-up equity shares. The offer price is ₹4.80 per equity share, payable in cash. This open offer complies with Regulation 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.